Avanos Medical, Inc. (NYSE: AVNS) reported Q4 EPS of $0.60, $0.11 better than the analyst estimate of $0.49. Revenue for the quarter came in at $217 million versus the consensus estimate of $217.3 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2023 EPS of $1.60-$1.80, versus the consensus of $1.68.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.